Your Notifications
All done, no notifications

What is Fuchs' endothelial dystrophy?

Fuchs endothelial dystrophy is a progressive eye condition that causes vision problems. It is a type of posterior corneal dystrophy that affects the innermost layer of corneal endothelial cells and Descemet’s membrane (the basement membrane). It causes loss of corneal endothelial cells, leading to fluid buildup (oedema) and small bumps called guttata that reduce visual clarity.

What is the Importance of Timely Treatment?

Timely assessment helps determine the severity of Fuchs’ endothelial dystrophy and whether treatment is needed. Mild cases may only require monitoring, while supportive treatments may help manage symptoms caused by corneal swelling. If the condition significantly affects vision, a corneal transplant may be recommended. Early evaluation also helps identify other eye conditions that may affect treatment planning and recovery

What are the common symptoms of Fuchs' endothelial dystrophy?

Symptoms and their intensity can vary. The following describes the symptoms associated with the disease.

  • Reduced corneal clarity
  • Eye movement-induced pain
  • Impaired vision at night or in low light
  • Reduced visual acuity (decreased central vision)
  • Cloudiness
  • Redness and swelling
  • Glare or sensitivity to light
  • Blurred vision
  • Vision that is worse in the morning and improves later in the day

Causes and Risk Factors of Fuchs' Endothelial Dystrophy

Causes

  • TCF4 gene changes: Changes in the TCF4 gene are particularly associated with Fuchs’ endothelial dystrophy. These changes can produce abnormal RNA that interferes with normal corneal endothelial cell function.
  • COL8A2 mutations: Changes in the COL8A2 gene are linked to early-onset forms of Fuchs’ endothelial dystrophy and may cause corneal changes at a younger age.
  • Other genes: Changes in genes and other factors may also increase the risk of developing FED in some people.

Risk Factors

  • Age: The earliest signs of Fuchs’ dystrophy may be visible in people in their 30s and 40s. But the disease usually affects vision after age 50.
  • Sex: Research shows evidence that females are at higher risk than males.
  • Family history: It is more common in people with a biological family history, which increases risk.
  • Genetic factors: Certain inherited genetic changes are associated with different forms of FECD.
  • Previous eye surgery: Procedures such as cataract surgery may place additional stress on corneal endothelial cells, particularly in people who already have FECD.

Latest Research and Technologies in the Treatment of Fuchs' Endothelial Dystrophy in Singapore

Recent advances in Fuchs' endothelial corneal dystrophy research in Singapore include AI-assisted analysis of widefield corneal images to assess endothelial cell changes and identify disease severity. The Singapore National Eye Centre and Singapore Eye Research Institute are also investigating tissue-engineered corneal endothelial grafts using cultivated human cells, with a first-in-human clinical trial initiated. These regenerative approaches aim to expand future treatment options, while endothelial keratoplasty, including DMEK, remains an established treatment for advanced disease.

Treatment options for Fuchs' Endothelial Dystrophy

Descemet Membrane Endothelial Keratoplasty (DMEK): This procedure replaces the damaged endothelium and Descemet's membrane with a thin layer of donor tissue. It is an established option for patients with visually significant endothelial dysfunction.

Descemet Stripping Automated Endothelial Keratoplasty (DSAEK): This procedure replaces the damaged endothelial layer with donor tissue that includes a thin layer of supporting corneal tissue. It may be appropriate depending on the patient's eye condition and the surgeon's assessment.

Cornea transplant : known as Descemet-stripping endothelial keratoplasty, or DSEK. In rare cases, you may need a complete cornea transplant, known as penetrating keratoplasty (PK).


Cost Start From 12000Explore Options

  • Clinical assessment:
    • Eye examination: Clinical assessment involves a comprehensive eye examination and a detailed clinical evaluation of the condition, followed by a medical eye history and physical examination
    • Slit-lamp examination: Performed to look for changes in the corneal structure, particularly bumps called guttata and corneal swelling. The doctor also checks visual acuity to see how the condition affects vision.
  • Imaging Tests:
    • Specular microscopy: Examines the endothelial cells and assesses their number, size, and shape.
    • Pachymetry: It measures the corneal thickness to track fluid accumulation
    • Anterior segment Optical coherence tomography (AS-OCT): A noninvasive imaging method that uses images of the back of your eye using reflected light.
  • In some patients, doctors may recommend hypertonic saline eye drops or ointments to reduce corneal swelling and temporarily improve symptoms. Lubricating eye drops and preservative-free artificial tears minimise ocular surface irritation and discomfort from corneal oedema. Ophthalmologists may prescribe other medicines, including corticosteroids, for specific indications such as postoperative care, and these require monitoring. Advanced disease causing significant visual impairment may require corneal transplantation.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Fuchs' Endothelial Dystrophy in Singapore

Mount Elizabeth Hospital: Top Doctors, and Reviews
Mount Elizabeth Hospital

Singapore, Singapore

Mount Elizabeth Hospital located in Singapore, Singapore is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • 345 bedded Hospital
  • Maternity wards
  • The Mount Elizabeth Patient Assistance Centre (MPAC)
  • 1 major operating unit with 12 operating rooms and 1 operating theatre dedicated to in vitro fertilisation (IVF)
  • Intensive Care Unit
  • High Dependency Unit (HDU)
  • Neonatal Intensive Care Unit (NICU)
  • Accident & Emergency Department
  • Rooms are categorized as Single rooms, 2-bedded rooms, 4-bedded rooms, Executive deluxe suite, Daffodil/Magnolia suite, VIP Room, and Royal Suite
  • All patient rooms are equipped with electric safe, LCD, sofa cum bed, wardrobe, radio channels, and much more
  • Parking lot
Message Us

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Singapore for Fuchs' Endothelial Dystrophy Treatment?

  • Specialised corneal surgeons: major eye centres have highly experienced corneal and endothelial disorder specialists and dedicated eye centres.
  • Advanced procedures: Selected centres perform DMEK and DSAEK, which replace the damaged endothelial layer while preserving most of the patient's cornea.
  • Modern diagnostic testing: Patients may have access to specular microscopy, corneal tomography, pachymetry, and anterior-segment OCT to support diagnosis and treatment planning.
  • Telemedicine service: singapore has telemedicine services, and AI-powered diagnostics improve access. Before travelling, patients should request details about the proposed procedure, expected costs, possible complications and arrangements for postoperative monitoring.

Frequently Asked Questions

Fuchs' endothelial dystrophy is a long-term condition, so exact recovery depends on the severity and the treatment required by the patient. If surgery such as DMEK or DSAEK is performed, vision may start improving within days to a few weeks, but it can take several weeks to a few months to stabilise.

Selected eye centres in singapore may offer diagnostic tests such as specular microscopy, corneal thickness measurement and anterior-segment OCT, as well as endothelial keratoplasty procedures such as DMEK and DSAEK. The availability of specific equipment and procedures varies between hospitals. Patients should confirm the diagnostic and surgical options available at their chosen centre.

Yes. Many hospitals in Singapore help international patients arrange consultations, treatment, hospital stays, accommodation, and travel. Some also offer language support and help with follow-up care.

Before choosing a recognised eye institute, research the doctor's experience, patient testimonials, hospital facilities, and access to advanced treatments to find the best doctor and hospital in Singapore for Fuchs’ endothelial dystrophy treatment. You can also get support from a mediGence medical tourism facilitator to help you choose the best doctor and facility.

Treatment outcomes depend on disease severity, overall eye health, and the procedure performed. DMEK and DSAEK can improve vision in many patients with advanced FECD, although complications or the need for additional procedures may occur. No single success rate applies to every patient or hospital in Singapore. Patients should ask their corneal specialist about expected outcomes, potential risks and the likelihood of further treatment.

Yes, many corneal specialists in Singapore diagnose and treat Fuchs' endothelial dystrophy, including with advanced procedures. Several eye centres in Singapore have also published research on newer treatment approaches. When choosing a doctor, consider their experience with corneal diseases, how many and what types of endothelial procedures they perform, and the hospital’s diagnostic and postoperative facilities.

The risks depend on the treatment used. Corneal transplantation may cause infection, inflammation, increased eye pressure, graft failure, or, less commonly, graft rejection. After DMEK or DSAEK, the donor tissue may not attach properly, and you may need an additional procedure. Full-thickness corneal transplantation has a different risk profile and may involve a longer recovery period. Regular follow-up with an ophthalmologist helps monitor healing and identify complications early.

If you have FECD and experience an eye injury, sudden vision loss, severe eye pain, redness, or increased light sensitivity, seek prompt evaluation by an ophthalmologist. Avoid rubbing or pressing on the eye, and use eye drops only if a healthcare professional recommends them.

If Fuchs' endothelial dystrophy becomes advanced and is not treated, it can cause lasting damage to the cornea. Severe swelling and scarring can cause significant vision loss. Treatments such as DMEK or DSAEK can clear the cornea and improve vision for many people.

Yes. Fuchs' endothelial dystrophy can affect daily life by causing blurred or cloudy vision, glare, or difficulty seeing clearly, particularly in the morning. These symptoms may make reading, driving, working, or using digital screens more challenging. The impact varies by person and depends on disease severity.

Yes. Fuchs' endothelial dystrophy can worsen gradually if left untreated, but its progression varies from person to person. As corneal endothelial cells become less effective, fluid may accumulate in the cornea, leading to ongoing swelling and blurred or cloudy vision. In advanced cases, prolonged swelling can cause painful blisters, corneal scarring, and significant vision loss.

Fuchs' endothelial dystrophy cannot currently be reliably prevented because genetic factors and ageing play an important role. Regular eye examinations can help identify early changes, particularly in people with a family history of the condition. If you have FECD, inform your ophthalmologist before eye surgery, as the condition may affect surgical planning and postoperative care. Protective eyewear can help prevent eye injuries, but it has not been shown to prevent FECD itself.

Yes. Fuchs' endothelial dystrophy becomes more common with age and is reported more often in women than in men. People with a family history of FECD or certain genetic changes may also be at higher risk. The age of onset varies: some inherited forms develop earlier in life, while others become noticeable later in adulthood.

Author

Dr. Abdullah Rahil
Dr. Abdullah Rahil

MPT (Neuro)

7 Years of Experience

Dr. Abdullah Rahil, M.P.T. (Neurology), is a dedicated physiotherapy professional specializing in orthopedic, neurological, and musculoskeletal rehabilitation. With strong clinical expertise, he focuses on improving patient mobility, reducing pain, and restoring functional independence through evidence-based rehabilitation techniques. He is skilled in advanced therapeutic approaches that support effective rehabilitation and recovery for a wide range of musculoskeletal and neurological conditions, focusing on improving mobility, reducing pain, and restoring functional independence. Dr. Rahil has extensive experience managing diverse rehabilitation cases. His patient-centered approach emphasizes personalized treatment plans, continuous assessment, and comprehensive rehabilitation to achieve optimal recovery outcomes. View More

Reviewer

Dr. Vidit Tripathi
Dr. Vidit Tripathi

ENT Surgeon

24 Years of Experience

One of the finest ENT Surgeon in New Delhi, India, Dr. Vidit Tripathi, has worked with several world class multidisciplinary hospitals over the years. Dr. Vidit Tripathi has over 24+ years of experience in his field. The specialist treats and manages a wide range of conditions such as Goiter, Radiation Necrosis in Neck, Neck Injury, Perforates Eardrum View More

Last Reviewed - January 2026